001     289449
005     20250318095250.0
024 7 _ |a 10.1093/mutage/geae012
|2 doi
024 7 _ |a pmid:38606763
|2 pmid
024 7 _ |a 0267-8357
|2 ISSN
024 7 _ |a 1464-3804
|2 ISSN
024 7 _ |a altmetric:162402817
|2 altmetric
037 _ _ |a DKFZ-2024-00771
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Giaccherini, M.
|b 0
245 _ _ |a A pleiotropy scan to discover new susceptibility loci for pancreatic ductal adenocarcinoma.
260 _ _ |a Oxford
|c 2025
|b Oxford Univ. Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1742287928_8523
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 2025 Mar 15;40(1):61-70
520 _ _ |a Pleiotropic variants (i.e., genetic polymorphisms influencing more than one phenotype) are often associated with cancer risk. A scan of pleiotropic variants was successfully conducted ten years ago in relation to pancreatic ductal adenocarcinoma susceptibility. However, in the last decade, genetic association studies performed on several human traits have greatly increased the number of known pleiotropic variants. Based on the hypothesis that variants already associated with a least one trait have a higher probability of association with other traits, 61,052 variants reported to be associated by at least one genome wide association study (GWAS) with at least one human trait were tested in the present study consisting of two phases (discovery and validation), comprising a total of 16,055 pancreatic ductal adenocarcinoma (PDAC) cases and 212,149 controls. The meta-analysis of the two phases showed two loci (10q21.1-rs4948550 (P=6.52×10-5) and 7q36.3-rs288762 (P=3.03×10-5) potentially associated with PDAC risk. 10q21.1-rs4948550 shows a high degree of pleiotropy and it is also associated with colorectal cancer risk while 7q36.3-rs288762 is situated 28,558 base pairs upstream of the Sonic Hedgehog (SHH) gene, which is involved in the cell differentiation process and PDAC etiopathogenesis. In conclusion, none of the single nucleotide polymorphisms (SNPs) showed a formally statistically significant association after correction for multiple testing. However, given their pleiotropic nature and association with various human traits including colorectal cancer, the two SNPs showing the best associations with PDAC risk merit further investigation through fine mapping and ad hoc functional studies.
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a genetic susceptibility
|2 Other
650 _ 7 |a pancreatic cancer
|2 Other
650 _ 7 |a pleiotropy
|2 Other
650 _ 7 |a single nucleotide polymorphism
|2 Other
700 1 _ |a Rende, M.
|b 1
700 1 _ |a Gentiluomo, M.
|b 2
700 1 _ |a Corradi, C.
|b 3
700 1 _ |a Archibugi, L.
|b 4
700 1 _ |a Ermini, S.
|b 5
700 1 _ |a Maiello, E.
|b 6
700 1 _ |a Morelli, L.
|b 7
700 1 _ |a van Eijck, C. H. J.
|b 8
700 1 _ |a Cavestro, G. M.
|b 9
700 1 _ |a Schneider, M.
|b 10
700 1 _ |a Mickevicius, A.
|b 11
700 1 _ |a Adamonis, K.
|b 12
700 1 _ |a Basso, D.
|b 13
700 1 _ |a Hlavac, V.
|b 14
700 1 _ |a Gioffreda, D.
|b 15
700 1 _ |a Talar-Wojnarowska, R.
|b 16
700 1 _ |a Schöttker, B.
|0 P:(DE-He78)c67a12496b8aac150c0eef888d808d46
|b 17
|u dkfz
700 1 _ |a Lovecek, M.
|b 18
700 1 _ |a Vanella, G.
|b 19
700 1 _ |a Gazouli, M.
|b 20
700 1 _ |a Uno, M.
|b 21
700 1 _ |a Malecka-Wojciesko, E.
|b 22
700 1 _ |a Vodicka, P.
|b 23
700 1 _ |a Goetz, M.
|b 24
700 1 _ |a Bijlsma, M. F.
|b 25
700 1 _ |a Petrone, M. C.
|b 26
700 1 _ |a Bazzocchi, F.
|b 27
700 1 _ |a Kiudelis, M.
|b 28
700 1 _ |a Szentesi, A.
|b 29
700 1 _ |a Carrara, S.
|b 30
700 1 _ |a Nappo, G.
|b 31
700 1 _ |a Brenner, H.
|0 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
|b 32
|u dkfz
700 1 _ |a Milanetto, A. C.
|b 33
700 1 _ |a Soucek, P.
|b 34
700 1 _ |a Katzke, V.
|0 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4
|b 35
|u dkfz
700 1 _ |a Peduzzi, G.
|b 36
700 1 _ |a Rizzato, C.
|b 37
700 1 _ |a Pasquali, C.
|b 38
700 1 _ |a Chen, Xuechen
|0 P:(DE-He78)c392ec8a090dcfbe801f135a6212caf9
|b 39
|u dkfz
700 1 _ |a Capurso, G.
|b 40
700 1 _ |a Hackert, T.
|b 41
700 1 _ |a Bueno-de-Mesquita, B.
|b 42
700 1 _ |a Uzunoglu, F. G. G.
|b 43
700 1 _ |a Hegyi, P.
|b 44
700 1 _ |a Greenhalf, W.
|b 45
700 1 _ |a Theodoropoulos, G. E. E.
|b 46
700 1 _ |a Sperti, C.
|b 47
700 1 _ |a Perri, F.
|b 48
700 1 _ |a Oliverius, M.
|b 49
700 1 _ |a Mambrini, A.
|b 50
700 1 _ |a Tavano, F.
|b 51
700 1 _ |a Farinella, R.
|b 52
700 1 _ |a Arcidiacono, P. G.
|b 53
700 1 _ |a Lucchesi, M.
|b 54
700 1 _ |a Bunduc, S.
|b 55
700 1 _ |a Kupcinskas, J.
|b 56
700 1 _ |a Di Franco, G.
|b 57
700 1 _ |a Stocker, S.
|b 58
700 1 _ |a Neoptolemos, J. P.
|b 59
700 1 _ |a Bambi, F.
|b 60
700 1 _ |a Jamroziak, K.
|b 61
700 1 _ |a Testoni, S. G. G.
|b 62
700 1 _ |a Aoki, M. N.
|b 63
700 1 _ |a Mohelnikova-Duchonova, B.
|b 64
700 1 _ |a Izbicki, J. R.
|b 65
700 1 _ |a Pezzilli, R.
|b 66
700 1 _ |a Lawlor, R. T.
|b 67
700 1 _ |a Kauffmann, E. F.
|b 68
700 1 _ |a López de Maturana, E.
|b 69
700 1 _ |a Malats, N.
|b 70
700 1 _ |a Canzian, F.
|0 P:(DE-He78)5323704270b6393dcea70186ffd86bca
|b 71
|u dkfz
700 1 _ |a Campa, D.
|b 72
773 _ _ |a 10.1093/mutage/geae012
|g p. geae012
|0 PERI:(DE-600)1497468-X
|n 1
|p 61-70
|t Mutagenesis
|v 40
|y 2025
|x 0267-8357
909 C O |p VDB
|o oai:inrepo02.dkfz.de:289449
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 17
|6 P:(DE-He78)c67a12496b8aac150c0eef888d808d46
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 32
|6 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 35
|6 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 39
|6 P:(DE-He78)c392ec8a090dcfbe801f135a6212caf9
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 71
|6 P:(DE-He78)5323704270b6393dcea70186ffd86bca
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2024
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2023-10-21
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-10-21
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-10-21
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b MUTAGENESIS : 2022
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2023-10-21
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2023-10-21
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2023-10-21
920 1 _ |0 I:(DE-He78)C070-20160331
|k C070
|l C070 Klinische Epidemiologie und Alternf.
|x 0
920 1 _ |0 I:(DE-He78)C120-20160331
|k C120
|l Primäre Krebsprävention
|x 1
920 1 _ |0 I:(DE-He78)HD01-20160331
|k HD01
|l DKTK HD zentral
|x 2
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l Epidemiologie von Krebs
|x 3
920 1 _ |0 I:(DE-He78)C055-20160331
|k C055
|l Genomische Epidemiologie
|x 4
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C070-20160331
980 _ _ |a I:(DE-He78)C120-20160331
980 _ _ |a I:(DE-He78)HD01-20160331
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a I:(DE-He78)C055-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21